Aurora Cannabis completes investing $3M in B.C. manufacturing facility
April 30, 2025
by CM Staff
The upgrades have resulted in optimal cultivation conditions, expanded output, and improved product quality.
EDMONTON — Aurora Cannabis completes multi-year investment of $3 million in improvements to its manufacturing facility in Pemberton, British Columbia.
The upgrades have resulted in optimal cultivation conditions, expanded output, and improved product quality. The site has been renamed to Aurora Alpine.
“Over the last three years, the investments we’ve made into this facility have resulted in doubling the yield and potency, reaching a record 33.7 per cent,” said Alex Miller, executive VP of operations and supply chain at Aurora. “The name Aurora Alpine reflects our commitment to achieving the highest degree of excellence.”
The former Whistler Medical Marijuana Company site was licensed in 2019. The GACP-certified facility enables Aurora to expand its global reach by exporting medical cannabis produced from the Aurora Alpine site internationally.
